Richard Whitley
Affiliations: | Hong Kong Polytechnic University (Hong Kong) |
Area:
Management Business AdministrationGoogle:
"Richard Whitley"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Whitley RJ, Hook EW. (2022) Shedding Patterns of Genital Herpes Simplex Virus Infections. Jama. 328: 1710-1711 |
| Bernstock JD, Bag A, Fiveash J, et al. (2020) Design and Rationale for First-In-Human Phase 1 Immunovirotherapy Clinical Trial of Oncolytic HSV G207 to Treat Malignant Pediatric Cerebellar Brain Tumors. Human Gene Therapy |
| Kong M, Zhang WW, Sewell K, et al. (2020) Azithromycin Treatment vs Placebo in Children With Respiratory Syncytial Virus-Induced Respiratory Failure: A Phase 2 Randomized Clinical Trial. Jama Network Open. 3: e203482 |
| Acosta E, Bowlin T, Brooks J, et al. (2020) Advances in the Development of Therapeutics for Cytomegalovirus Infections. The Journal of Infectious Diseases. 221: S32-S44 |
| Whitley R. (2020) Mark Prichard: Scholar, family man and friend. Antiviral Research. 104715 |
| Roosenhoff R, Reed V, Kenwright A, et al. (2019) Viral Kinetics and Resistance Development in Children Treated with Neuraminidase Inhibitors: The Influenza Resistance Information Study (IRIS). Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America |
| Whitley RJ. (2019) Congenital Cytomegalovirus and Neonatal Herpes Simplex Virus Infections: To Treat or Not to Treat? The Pediatric Infectious Disease Journal. 38: S60-S63 |
| Akhtar LN, Bowen CD, Renner DW, et al. (2019) Genotypic and Phenotypic Diversity of Herpes Simplex Virus 2 within the Infected Neonatal Population. Msphere. 4 |
| Whitley RJ. (2019) Herpes Simplex Virus in Children. Current Treatment Options in Neurology. 4: 231-237 |
| Cassady K, Miller K, Prasad N, et al. (2019) ATIM-32. PREDICTORS OF IMPROVED SURVIVAL FOLLOWING ONCOLYTIC VIRUS TREATMENT IN PATIENTS WITH RECURRENT GLIOBLASTOMA: GENE EXPRESSION ANALYSIS FROM THE PHASE IB G207 CLINICAL TRIAL Neuro-Oncology. 21: vi8-vi8 |